-
Entity
-
Individual
-
Location
-
C/O Xilio Therapeutics, Inc., 828 Winter Street, Waltham, MA
-
Summary
-
The estimated net worth of Kevin Brennan is at least $18.7K dollars as of January 3, 2025. Kevin Brennan is the SVP, FINANCE AND ACCOUNTING of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $18.7K.